You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on ...

Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.

Pfizer offers a 7% dividend yield, lower COVID sales, oncology and cardiometabolic focus, and growth from Metsera and ...

Pfizer Inc. (NYSE:PFE) is one of the latest stocks on Jim Cramer’s radar. Cramer noted that the company could not perform as ...

Jon Smith explains why investors can look across the pond for stocks with attractive dividend forecasts and shares a specific ...

With big yields, these turnaround stocks look like they are attractively priced for those who can handle some uncertainty.

The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...

A judge denied Pfizer Inc.’s request to temporarily block Novo Nordisk A/S’ $10 billion bid to acquire the obesity startup ...

Image courtesy by QUE.com A large number of US companies pay dividends. Dividend-paying stocks are often categorized based on their ...

A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 ...

While we remain bullish on gold stocks overall, we note that Torex trades at a significant discount to the rest of the sector ...